Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]

Detalles Bibliográficos
Autores principales: Idrus, Hasta Handayani, Sunarno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910095/
https://www.ncbi.nlm.nih.gov/pubmed/36776449
http://dx.doi.org/10.2147/DDDT.S405817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910095/
https://www.ncbi.nlm.nih.gov/pubmed/36776449
http://dx.doi.org/10.2147/DDDT.S405817

Ejemplares similares